Holistic management of symptomatic reflux: rising to the challenge of proton pump inhibitor overuse
[摘要] THE ISSUE OF CONTINUED PPI OVERUSE Proton pump inhibitors (PPIs) are medications that suppress the production of stomach acid.1 Introduced to clinical practice over 30 years ago, PPIs gained rapid popularity for the effective treatment of acid-related disorders and are now some of the most prescribed therapeutics worldwide.2 PPIs are indicated for conditions such as gastro-oesophageal reflux disease (GORD), peptic ulcer disease, Zollinger–Ellison syndrome, and Helicobacter pylori infection, and are also recommended for gastroprotection against non-steroidal anti-inflammatory drugs (NSAIDs) and anti-platelet treatments that can induce pathologies in at-risk patients.1GORD is prevalent in populations adopting a Western-style diet characterised by large and calorie-dense meals, and presents a significant individual, economic, and societal burden.
[发布日期] [发布机构]
[效力级别] [学科分类] 卫生学
[关键词] [时效性]